| Type |
Details |
Score |
| Gene |
| Type: |
gene |
| Organism: |
chicken |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, western clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
chimpanzee |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| HT Experiment |
| Series Id: |
GSE60875 |
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
ArrayExpress |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tsai WW |
| Year: |
2013 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
PRMT5 modulates the metabolic response to fasting signals. |
| Volume: |
110 |
| Issue: |
22 |
| Pages: |
8870-5 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wei H |
| Year: |
2013 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB. |
| Volume: |
110 |
| Issue: |
33 |
| Pages: |
13516-21 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
656 |
| Description: |
Omega-N-methylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
656 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
563 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
563 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
19 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
19 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
98 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
98 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
102 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
102 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
190 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
190 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
927 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
927 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
49 |
| Description: |
Omega-N-methylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
49 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
371 |
| Description: |
Omega-N-methylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
371 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
57 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
57 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
163 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
163 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
549 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
549 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
192 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
192 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
19 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
19 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
100 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
100 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
104 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
104 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
192 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
192 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
104 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
104 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
100 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
100 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
19 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
19 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
19 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
19 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
192 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
192 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
100 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
100 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
104 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
104 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
192 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
192 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
104 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
104 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
100 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
100 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
19 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
19 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
192 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
192 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
100 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
100 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
104 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
104 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
19 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
19 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
98 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
98 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
102 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
102 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
190 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
190 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
19 |
| Description: |
Symmetric dimethylarginine; by PRMT5 |
| Type: |
modified residue |
| End: |
19 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hing ZA |
| Year: |
2023 |
| Journal: |
Nat Commun |
| Title: |
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation. |
| Volume: |
14 |
| Issue: |
1 |
| Pages: |
97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Igarashi H |
| Year: |
2009 |
| Journal: |
Mol Immunol |
| Title: |
GANP suppresses the arginine methyltransferase PRMT5 regulating IL-4-mediated STAT6-signaling to IgE production in B cells. |
| Volume: |
46 |
| Issue: |
6 |
| Pages: |
1031-41 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yan F |
| Year: |
2014 |
| Journal: |
Cancer Res |
| Title: |
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. |
| Volume: |
74 |
| Issue: |
6 |
| Pages: |
1752-65 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Azzouz TN |
| Year: |
2005 |
| Journal: |
J Biol Chem |
| Title: |
Toward an assembly line for U7 snRNPs: interactions of U7-specific Lsm proteins with PRMT5 and SMN complexes. |
| Volume: |
280 |
| Issue: |
41 |
| Pages: |
34435-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Feng M |
| Year: |
2024 |
| Journal: |
Cell Death Dis |
| Title: |
The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment. |
| Volume: |
15 |
| Issue: |
10 |
| Pages: |
758 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wei X |
| Year: |
2020 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. |
| Volume: |
117 |
| Issue: |
45 |
| Pages: |
28068-28079 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
1810 |
| Description: |
Symmetric dimethylarginine; alternate; by PRMT5 |
| Type: |
modified residue |
| End: |
1810 |
|
•
•
•
•
•
|
| Allele |
| Name: |
protein arginine N-methyltransferase 5; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chakrapani B |
| Year: |
2021 |
| Journal: |
Life Sci Alliance |
| Title: |
The uncharacterized protein FAM47E interacts with PRMT5 and regulates its functions. |
| Volume: |
4 |
| Issue: |
3 |
|
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
4 |
| Description: |
Symmetric dimethylarginine; by PRMT5 and PRMT7; alternate |
| Type: |
modified residue |
| End: |
4 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
1 |
| Description: |
Coordinator of PRMT5 and differentiation stimulator |
| Type: |
chain |
| End: |
173 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
291 |
| Description: |
Asymmetric dimethylarginine; by PRMT1 and PRMT5 |
| Type: |
modified residue |
| End: |
291 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling. |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
Loss of PRMT5 Promotes PDGFR Degradation during Oligodendrocyte Differentiation and Myelination. |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
Arginine methylation by PRMT5 at a naturally occurring mutation site is critical for liver metabolic regulation by small heterodimer partner. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pal S |
| Year: |
2004 |
| Journal: |
Mol Cell Biol |
| Title: |
Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. |
| Volume: |
24 |
| Issue: |
21 |
| Pages: |
9630-45 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Meister G |
| Year: |
2001 |
| Journal: |
Curr Biol |
| Title: |
Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. |
| Volume: |
11 |
| Issue: |
24 |
| Pages: |
1990-4 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
199
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
394
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
101
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
415
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
230
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
402
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
159
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
121
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
260
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
415
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
101
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
430
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
The function of this family of proteins from metazoa is not known. Human FAM47E localizes the arginine methyltransferase PRMT5 to chromatin and, thus, promotes histone methylation []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Paul C |
| Year: |
2019 |
| Journal: |
FEBS Open Bio |
| Title: |
Coprs inactivation leads to a derepression of LINE1 transposons in spermatocytes. |
| Volume: |
9 |
| Issue: |
1 |
| Pages: |
159-168 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the N-terminal TIM barrel domain of PRMT5.Proteins containing this domain includes Skb1 from S. pombe [], Hsl7 from S. cerevisiae []and their homologues PRMT5 from animals [, , ]and plants []. Skb1 is a mediator of hyperosmotic stress response in Schizosaccharomyces pombe []. Plant PMRT15 is involved in the post-transcriptional regulation of the circadian clock []. Human PRMT5 is a component of multiple protein complexes and contributes to essential cellular processes, such as RNA transport and splicing, cell cycle regulation, tumour growth, and chromatin remodelling, leading to either gene silencing or activation []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the C-terminal oligomerisation domain of PRMT5.Proteins containing this domain includes Skb1 from S. pombe [], Hsl7 from S. cerevisiae []and their homologues PRMT5 from animals [, , ]and plants []. Skb1 is a mediator of hyperosmotic stress response in Schizosaccharomyces pombe []. Plant PMRT15 is involved in the post-transcriptional regulation of the circadian clock []. Human PRMT5 is a component of multiple protein complexes and contributes to essential cellular processes, such as RNA transport and splicing, cell cycle regulation, tumour growth, and chromatin remodelling, leading to either gene silencing or activation []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Paul C |
| Year: |
2015 |
| Journal: |
Biol Open |
| Title: |
The Wnt-target gene Dlk-1 is regulated by the Prmt5-associated factor Copr5 during adipogenic conversion. |
| Volume: |
4 |
| Issue: |
3 |
| Pages: |
312-6 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jansson M |
| Year: |
2008 |
| Journal: |
Nat Cell Biol |
| Title: |
Arginine methylation regulates the p53 response. |
| Volume: |
10 |
| Issue: |
12 |
| Pages: |
1431-9 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
Mus caroli |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|